Trial Profile
A Phase I Exploratory Study to Assess the Pharmacokinetics of Single Inhaled Dose of Cannabis (Delta-9-Tetrahydrocannabinol / Cannabidiol) Administered by Vaporization Using a 4-Day Dose Titration In Healthy Male And Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2020
Price :
$35
*
At a glance
- Drugs Marijuana (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Pharmacokinetics
- 03 Jul 2020 Status changed from planning to completed.
- 01 Nov 2018 According to a Tetra Bio Pharma media release, the company has obtained approval from Health Canada to conduct this trial and expects to begin and end the trial in Q4 2018.
- 27 Sep 2018 New trial record